共 17 条
[1]
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.[J].Laurie H. Sanders;J. Timothy Greenamyre.Free Radical Biology and Medicine.2013,
[2]
Chronic exposure to rotenone; a dopaminergic toxin; results in peripheral neuropathy associated with dopaminergic damage.[J].Zbigniew K. Binienda;Sumit Sarkar;Lamya Mohammed-Saeed;Bobby Gough;Michael A. Beaudoin;Syed F. Ali;Merle G. Paule;Syed Z. Imam.Neuroscience Letters.2013,
[3]
Use of viral vectors to create animal models for Parkinson's disease.[J]..Neurobiology of Disease.2011, 2
[4]
Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide; rotenone.[J].P. Mulcahy;A. O'Doherty;A. Paucard;T. O'Brien;D. Kirik;E. Dowd.Neuroscience.2011,
[5]
Mouse models for LRRK2 Parkinson's disease.[J].Qing Xu;Sushila Shenoy;Chenjian Li.Parkinsonism and Related Disorders.2011,
[6]
Adh1 and Adh1 / 4 knockout mice as possible rodent models for presymptomatic Parkinson's disease.[J]..Behavioural Brain Research.2011, 1
[8]
Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.[J].Anwar Norazit;Adrian C.B. Meedeniya;Maria Nga Nguyen;Alan Mackay-Sim.Brain Research.2010,
[9]
Modeling sporadic Parkinson's disease by silencing the ubiquitin E3 ligase component; SKP1A.[J].Silvia A. Mandel;Tali Fishman-Jacob;Moussa B.H. Youdim.Parkinsonism and Related Disorders.2009,

